Momenta Pharmaceuticals Performance
The company secures a Beta (Market Risk) of 0.0, which conveys not very significant fluctuations relative to the market. the returns on MARKET and Momenta Pharmaceuticals are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Momenta Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Momenta Pharmaceuticals is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors. ...more
| Fifty Two Week Low | 15.13 | |
| Target High Price | 52.50 | |
| Fifty Two Week High | 52.53 | |
| Target Low Price | 52.50 |
Momenta |
Momenta Pharmaceuticals Relative Risk vs. Return Landscape
If you would invest 0.00 in Momenta Pharmaceuticals on January 25, 2024 and sell it today you would earn a total of 0.00 from holding Momenta Pharmaceuticals or generate 0.0% return on investment over 90 days. Momenta Pharmaceuticals is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Momenta, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Momenta Pharmaceuticals Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Momenta Pharmaceuticals' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Momenta Pharmaceuticals, and traders can use it to determine the average amount a Momenta Pharmaceuticals' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| MNTA |
Based on monthly moving average Momenta Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Momenta Pharmaceuticals by adding Momenta Pharmaceuticals to a well-diversified portfolio.
Momenta Pharmaceuticals Fundamentals Growth
Momenta Stock prices reflect investors' perceptions of the future prospects and financial health of Momenta Pharmaceuticals, and Momenta Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Momenta Stock performance.
| Return On Equity | -64.36 | |||
| Return On Asset | -30.56 | |||
| Operating Margin | (815.34) % | |||
| Current Valuation | 5.71 B | |||
| Shares Outstanding | 118.97 M | |||
| Price To Earning | (7.85) X | |||
| Price To Book | 15.41 X | |||
| Price To Sales | 207.61 X | |||
| Revenue | 30.07 M | |||
| EBITDA | (240.91 M) | |||
| Cash And Equivalents | 436.3 M | |||
| Cash Per Share | 3.75 X | |||
| Total Debt | 37.09 M | |||
| Debt To Equity | 0.09 % | |||
| Book Value Per Share | 3.41 X | |||
| Cash Flow From Operations | (199.23 M) | |||
| Earnings Per Share | (2.09) X | |||
| Total Asset | 421.04 M | |||
| Retained Earnings | (1.06 B) | |||
| Current Asset | 374.71 M | |||
| Current Liabilities | 38.78 M | |||
Things to note about Momenta Pharmaceuticals performance evaluation
Checking the ongoing alerts about Momenta Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Momenta Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Momenta Pharmaceuticals is not yet fully synchronised with the market data | |
| Momenta Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Momenta Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 30.07 M. Net Loss for the year was (227.83 M) with loss before overhead, payroll, taxes, and interest of (73.76 M). | |
| Momenta Pharmaceuticals currently holds about 436.3 M in cash with (199.23 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.75. | |
| Over 99.0% of the company shares are owned by institutional investors |
- Analyzing Momenta Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Momenta Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
- Examining Momenta Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Momenta Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Momenta Pharmaceuticals' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Momenta Pharmaceuticals' stock. These opinions can provide insight into Momenta Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Consideration for investing in Momenta Stock
If you are still planning to invest in Momenta Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Momenta Pharmaceuticals' history and understand the potential risks before investing.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |